Lynch & Associates Medtronic PLC Transaction History
Lynch & Associates
- $510 Million
- Q4 2025
A detailed history of Lynch & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Lynch & Associates holds 15,197 shares of MDT stock, worth $1.46 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
15,197
Previous 10,827
40.36%
Holding current value
$1.46 Million
Previous $1.03 Million
41.9%
% of portfolio
0.29%
Previous 0.2%
Shares
8 transactions
Others Institutions Holding MDT
# of Institutions
2,508Shares Held
1.07BCall Options Held
9.37MPut Options Held
6.41M-
Vanguard Group Inc Valley Forge, PA127MShares$12.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.8 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.5MShares$5.82 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY52.2MShares$5.03 Billion0.33% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.7MShares$2.96 Billion0.57% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $128B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...